SOURCE: SkyePharma PLC

October 31, 2006 02:02 ET

SkyePharma PLC announces Conference Presentation

London -- (MARKET WIRE) -- October 31, 2006 --

For Immediate Release                                 31st October 2006



                                 SkyePharma PLC



                   SKYEPHARMA TO PRESENT AT COWEN AND COMPANY

                    7TH ANNUAL GLOBAL HEALTH CARE CONFERENCE

LONDON, UK, 31 October 2006 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announces today that the Company's Chief Executive Officer, Frank Condella, will make a presentation at the Cowen and Company 7th Annual Global Health Care Conference at the Landmark London Hotel in London, UK. Mr. Condella will deliver his presentation on Tuesday, November 7, 2006 at 5.30 p.m. (GMT). Investors may access a live webcast of the presentation at www.skyepharma.com under the Investor Relations tab. The presentation will be archived for 3 months.

For further information please contact:


SkyePharma PLC                                      +44 207 491 1777
Frank Condella, Chief Executive Officer
Ken Cunningham, Chief Operating Officer

Buchanan Communications                              +44 207 466 5000
Tim Anderson / Mark Court / Rebecca Skye Dietrich

The Trout Group                                      + 1 617 583 1308
Seth Lewis

About SkyePharma PLC

SkyePharma PLC develops pharmaceutical products benefiting from world-leading drug delivery technologies that provide easier-to-use and more effective drug formulations. There are now eleven approved products incorporating SkyePharma's technologies in the areas of oral, injectable, inhaled and topical delivery, supported by advanced solubilisation capabilities. For more information, visit www.skyepharma.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange